Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Aug 1;176(2):399–405. doi: 10.1084/jem.176.2.399

Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis

PMCID: PMC2119309  PMID: 1500852

Abstract

Strain C.B17 scid/scid (SCID) mice, which lack functional T and B lymphocytes, show heightened susceptibility to the induction of thymic lymphomas by x-irradiation. Susceptibility is highest in thymus- chimeric SCID-BL mice (thymectomized SCID mice bearing a C57BL thymus graft). All SCID-BL lymphomas originate in the cells of the thymic graft (C57BL type) and lack murine leukemia virus expression. Both SCID and SCID-BL lymphomas are phenotypically CD4-8+ and/or CD4+8+, but only the SCID-BL tumors express CD3. Injection of C57BL or BALB/c bone marrow into irradiated SCID-BL mice prevents lymphoma development, but SCID marrow is completely ineffective. The results suggest that the scid condition enhances the activity of a putative lymphomagenic agent induced in the bone marrow by x-irradiation and that C57BL thymic cells are highly sensitive targets. Moreover, the failure of SCID bone marrow to protect against lymphomagenesis vs. the efficacy of marrow from immunocompetent donors points to involvement of T or B lineage cells in this process.

Full Text

The Full Text of this article is available as a PDF (681.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. Y., Ruddle N. H., Lipman M. B., Richards F. F. Tumor induction by immunologically activated murine leukemia virus. J Exp Med. 1973 May 1;137(5):1163–1179. doi: 10.1084/jem.137.5.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biedermann K. A., Sun J. R., Giaccia A. J., Tosto L. M., Brown J. M. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1394–1397. doi: 10.1073/pnas.88.4.1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boniver J., Declève A., Finn O. J., Honsik C., Lieberman M., Kaplan H. S. Detection of infectious centers in C57BL/Ka lymphoid cell populations infected in vitro by the radiation leukemia virus. Cancer Res. 1980 Mar;40(3):544–549. [PubMed] [Google Scholar]
  4. Bosma M. J., Carroll A. M. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323–350. doi: 10.1146/annurev.iy.09.040191.001543. [DOI] [PubMed] [Google Scholar]
  5. Custer R. P., Bosma G. C., Bosma M. J. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol. 1985 Sep;120(3):464–477. [PMC free article] [PubMed] [Google Scholar]
  6. Declève A., Niwa O., Hilgers J., Kaplan H. S. An improved murine leukemia virus immunofluorescence assay. Virology. 1974 Feb;57(2):491–502. doi: 10.1016/0042-6822(74)90188-3. [DOI] [PubMed] [Google Scholar]
  7. Dorshkind K., Pollack S. B., Bosma M. J., Phillips R. A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 1985 Jun;134(6):3798–3801. [PubMed] [Google Scholar]
  8. Fulop G. M., Phillips R. A. The scid mutation in mice causes a general defect in DNA repair. Nature. 1990 Oct 4;347(6292):479–482. doi: 10.1038/347479a0. [DOI] [PubMed] [Google Scholar]
  9. Gleichmann E., Gleichmann H., Schwartz R. S., Weinblatt A., Armstrong Y. K. Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model. J Natl Cancer Inst. 1975 Jan;54(1):107–116. doi: 10.1093/jnci/54.1.107. [DOI] [PubMed] [Google Scholar]
  10. Gorelik E., Rosen B., Copeland D., Weatherly B., Herberman R. B. Evaluation of role of natural killer cells in radiation-induced leukemogenesis in mice. J Natl Cancer Inst. 1984 Jun;72(6):1397–1403. [PubMed] [Google Scholar]
  11. Guidos C. J., Weissman I. L., Adkins B. Intrathymic maturation of murine T lymphocytes from CD8+ precursors. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7542–7546. doi: 10.1073/pnas.86.19.7542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Humblet C., Defresne M. P., Greimers R., Rongy A. M., Boniver J. Further studies on the mechanism of radiation induced thymic lymphoma prevention by bone marrow transplantation in C57BL mice. Leukemia. 1989 Nov;3(11):813–818. [PubMed] [Google Scholar]
  13. KAPLAN H. S., BROWN M. B., PAULL J. Influence of bone-marrow injections on involution and neoplasia of mouse thymus after systemic irradiation. J Natl Cancer Inst. 1953 Oct;14(2):303–316. doi: 10.1093/jnci/14.2.303. [DOI] [PubMed] [Google Scholar]
  14. KAPLAN H. S., HIRSCH B. B., BROWN M. B. Indirect induction of lymphomas in irradiated mice. IV. Genetic evidence of the origin of the tumor cells from the thymic grafts. Cancer Res. 1956 Jun;16(5):434–436. [PubMed] [Google Scholar]
  15. Kaplan H. S. On the natural history of the murine leukemias: presidential address. Cancer Res. 1967 Aug;27(8):1325–1340. [PubMed] [Google Scholar]
  16. LIEBERMAN M., KAPLAN H. S. Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science. 1959 Aug 14;130(3372):387–388. doi: 10.1126/science.130.3372.387. [DOI] [PubMed] [Google Scholar]
  17. Lieberman M., Declève A., Ricciardi-Castagnoli P., Boniver J., Finn O. J., Kaplan H. S. Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL/Ka mice. Int J Cancer. 1979 Aug;24(2):168–177. doi: 10.1002/ijc.2910240208. [DOI] [PubMed] [Google Scholar]
  18. Lieberman M., Hansteen G. A., McCune J. M., Scott M. L., White J. H., Weissman I. L. Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen. J Exp Med. 1987 Dec 1;166(6):1883–1893. doi: 10.1084/jem.166.6.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Majumdar A. S., Guidos C., Kaneshima H., White J. H., Marian J., Lieberman M., Weissman I. L. An immunodominant murine lymphoma cell surface heterodimer marks thymic progenitor subsets. J Immunol. 1990 Jan 1;144(1):111–121. [PubMed] [Google Scholar]
  20. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988 Sep 23;241(4873):1632–1639. doi: 10.1126/science.241.4873.1632. [DOI] [PubMed] [Google Scholar]
  21. Rudolphi A., Spiess S., Conradt P., Claesson M. H., Reimann J. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Eur J Immunol. 1991 Jul;21(7):1591–1600. doi: 10.1002/eji.1830210704. [DOI] [PubMed] [Google Scholar]
  22. Schwartz R. S., Beldotti L. Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder. Science. 1965 Sep 24;149(3691):1511–1514. doi: 10.1126/science.149.3691.1511. [DOI] [PubMed] [Google Scholar]
  23. Shores E. W., Sharrow S. O., Uppenkamp I., Singer A. T cell receptor-negative thymocytes from SCID mice can be induced to enter the CD4/CD8 differentiation pathway. Eur J Immunol. 1990 Jan;20(1):69–77. doi: 10.1002/eji.1830200111. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES